Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.
The annual price was approx us$160,000 per patient.
Thats us$1.6b revenue annually.
Pharma industry colloquial description for a blockbuster, is greater than us$1b revenue. It was a throwaway line from Michael, trying to describe how big we could be without giving specifics, imho.
Relyvrio, were on track for 10,000 patient level in the USA....
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |